Envista Holdings Corp

Envista Holdings Corp

NVST
Envista Holdings CorpUS flagNew York Stock Exchange
28.28
USD
+0.20
- -
4.60BMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
18.02
18.18
18.4
16.78
12.09
15.56
15.77
15.38
14.58
16.19
17.41
Basic EPS, GAAP
1.76
1.95
1.49
1.6
0.21
2.11
1.49
-0.6
-6.5
0.28
0.58
Free Cash Flow per Basic Share
2.38
2.01
2.12
2.35
1.48
1.9
0.66
1.3
1.76
1.37
1.51
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
32.27
31.19
22.31
23.25
25.11
25.78
24.34
17.04
18.96
19.16
Tangible Book Value per Share
- -
0.68
0.69
-6.63
-4
-0.75
-2.31
-0.42
0.13
0.74
0.68
Basic Weighted Avg Shares
155
155
155
136
160
161
163
167
172
168
164
Sales/Revenue/Turnover
2,785
2,811
2,844
2,285
1,929
2,509
2,569
2,566
2,511
2,720
2,856
Operating Margin (%)
14.46
13.75
10.49
10.32
2.25
12.2
13.36
12.27
5.46
8.67
10.4
Depreciation Expense
127
121
130
168
163
152
162
163
154
151
151
Net Income, GAAP
272
301
231
218
33
340
243
-100
-1,119
47
95
Effective Tax Rate (%)
32.29
22.14
23.38
21.22
- -
- -
16.17
- -
- -
73.48
59.42
Profit Margin (%)
9.77
10.71
8.11
9.52
1.73
13.57
9.46
-3.9
-44.56
1.73
3.33
Working Capital
- -
166
146
293
-94
628
188
963
910
1,174
1,151
LT Debt
- -
- -
- -
1,507
1,060
1,004
992
1,508
1,397
1,559
1,550
Total Equity
- -
4,995
4,826
3,543
3,721
4,058
4,207
4,174
2,935
3,106
3,076
Return on Invested Capital (%)
- -
12.04
4.66
3.75
- -
- -
5.09
- -
- -
1.35
2.54
Return on Capital (%)
- -
12.06
4.7
4.45
- -
- -
4.89
- -
- -
1.23
2.33
Return on Common Equity (%)
- -
12.07
4.7
5.2
0.92
8.76
5.88
-2.39
-31.47
1.56
3.06

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
39
39
38
LT Borrowings
1,448
1,439
1,436
LT Finance Leases
110
111
113
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
164
163
161
Market Capitalization
3,556
4,133
4,232

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,027
1,919
1,958
Cash, Cash Equivalents & STI
1,212
1,083
1,126
Accounts Receivable, Net
430
437
437
Inventories
288
300
291
Total Current Liabilities
853
787
807
Payables & Accruals
252
238
250
ST Debt
39
39
38
Deferred Revenue
185
188
192

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-2.38%
5.84%
Free Cash Flow
- -
16.67%
-23.89%
Net Income, GAAP
- -
332.97%
-104.2%
Sales/Revenue/Turnover
- -
7.7%
8.32%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
624
633
601
653
2,511
2025
617
682
670
751
2,720
2026
706
730
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
-6.69
0.05
0.01
-6.5
2025
0.1
0.16
-0.18
0.2
0.28
2026
0.24
0.33
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Paul A. Keel
Full Time Employees
12,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
Building E Brea CA United States of America 92821-6208
IPO Date
Sep 18, 2019
Business
Envista Holdings Corp (NYSE: NVST) develops and manufactures a broad portfolio of dental products and technologies for dental professionals worldwide. The company operates through two primary segments: Specialty Products & Technologies, which offers dental implant systems, prosthetics, clear aligners, brackets and wires, orthodontic and laboratory products; and Equipment & Consumables, which provides digital imaging systems, dental practice equipment, endodontic systems, restorative and impression materials, bonding agents and cements, and infection prevention products. Envista serves dental offices, orthodontists, oral surgeons, and laboratories with innovative solutions supporting integrated digital workflows, training programs, and comprehensive patient care tools across more than 120 countries. Founded in 2019 as a spin-off from Danaher Corp and headquartered in Brea, California, the company encompasses over 30 trusted brands with more than 125 years of combined industry heritage. In June 2025, Envista acquired Alpha-Bio France to strengthen its implant and prosthetics offerings in Europe; the company continues strategic mergers and acquisitions to expand its global reach and technological capabilities, anchored by the Envista Business System for operational excellence.

Company News

APIChatGPT
  • Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?

  • 4 Best PEG-Driven Value Stocks to Buy Now for Strong Returns

  • Best Momentum Stocks to Buy for August 10th

  • Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trends

  • Best Growth Stocks to Buy for August 10th

  • Envista Q2 Earnings Call Highlights

  • NVST vs. ABT: Which Stock Is the Better Value Option?

  • Here's Why Envista (NVST) is a Strong Value Stock

  • Envista Holdings Corporation (NVST) Q2 2026 Earnings Call Transcript

  • Envista (NVST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Envista (NVST) Q2 Earnings and Revenues Surpass Estimates

  • Envista Reports Second Quarter 2026 Results

  • Envista (NVST) Stock Jumps 5.2%: Will It Continue to Soar?

  • Envista to Host Investor Day on September 17, 2026

  • Does NVST Stock Still Deserve a Place in Your Portfolio?

  • Envista Schedules Second Quarter 2026 Earnings Call

  • NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?

  • Here's Why You Should Retain NVST Stock in Your Portfolio for Now

  • Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?

  • Is NVST Attractive at 15.1x Forward Earnings?